Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Insulin resistance linked to obesity may increase COVID-19 severity.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Use minoxidil for hair loss treatment, and finasteride for men.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.